WSA
MDCO

Wall Street Associates’s Medicines Co MDCO Stock Holding History

Wall Street Associates’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-26,859
Closed -$1M – 291
2015
Q4 		$1M Sell
26,859
-700
-3% -$26.5K 0.28% 125
2015
Q3 		$1.05M Sell
27,559
-3,300
-11% -$116K 0.2% 136
2015
Q2 		$883K Buy
+30,859
New +$860K 0.08% 223

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wall Street Associates's MDCO Position: Q1 2016 in Review

Wall Street Associates sold out of Medicines Co (MDCO) in Q1 2016, closing a stake of 26,859 shares — an estimated $1M sold.

Wall Street Associates first reported a position in MDCO in Q2 2015 and held it in 3 quarters. The position peaked at $1.05M in Q3 2015. 181 funds tracked by Wall St. Rank hold MDCO as of Q1 2016.

  • Wall Street Associates reported no remaining Medicines Co position as of Q1 2016 after selling out during the quarter.
  • Wall Street Associates sold 26,859 Medicines Co shares in Q1 2016, an estimated $1M.
  • Wall Street Associates first reported a position in Medicines Co in Q2 2015 and held it in 3 quarters.
  • Wall Street Associates's Medicines Co position peaked at $1.05M in Q3 2015.
  • 181 funds tracked by Wall St. Rank held Medicines Co as of Q1 2016.

Based on Wall Street Associates's 13F filing for Q1 2016, filed 13 May 2016.